Pharmaceutical Technology2 天
Risk adjusted net present value: What is the current valuation of Philogen’s Fibromun?
Fibromun is a fusion protein commercialized by Philogen, with a leading Phase III program in Soft Tissue Sarcoma.
Pharmaceutical Technology5 天
Risk adjusted net present value: What is the current valuation of Pharma Mar’s Ecubectedin?
Ecubectedin is a small molecule commercialized by Pharma Mar, with a leading Phase II program in Sarcomas;Solid Tumor;Leiomyosarcoma;Liposarcoma;Synovial Sarcoma.